{"transactions":[{"id":909359,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":66852,"kind":"person","name":"Khan Bilal Arshad","position":1,"cik":"0002108044","reported_name":"Khan Bilal Arshad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-11T21:07:19.000Z","date":"2026-02-09","kind":"purchase","planned":false,"acquired":true,"shares":115000,"price":16,"value":1840000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by New World Medical, Inc. (New World Medical). The Reporting Person is the Chief Executive Officer of New World Medical and as such has voting and investment control over the shares held by New World Medical.  The Reporting Person disclaims beneficial ownership of such shares, except to the extent of their pecuniary interest in the shares."}],"balance_after":251427,"source":{"system":"sec-edgar","filing":"0002108044-26-000006","document":"form4-02112026_090215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1778922/000210804426000006/form4-02112026_090215.xml","form_type":"4"}},{"id":909358,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":66852,"kind":"person","name":"Khan Bilal Arshad","position":1,"cik":"0002108044","reported_name":"Khan Bilal Arshad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-11T21:07:19.000Z","date":"2026-02-09","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":16,"value":320000.0,"ownership":{"direct":true},"balance_after":25450,"source":{"system":"sec-edgar","filing":"0002108044-26-000006","document":"form4-02112026_090215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778922/000210804426000006/form4-02112026_090215.xml","form_type":"4"}},{"id":913920,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":66852,"kind":"person","name":"Khan Bilal Arshad","position":1,"cik":"0002108044","reported_name":"Khan Bilal Arshad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-02-09T21:50:13.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":13700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2026 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean February 5, 2026."}],"balance_after":13700,"derivative":{"exercise_price":16,"expiration_date":"2036-02-05","underlying":"Common Stock","underlying_shares":13700},"source":{"system":"sec-edgar","filing":"0002108044-26-000004","document":"form4-02092026_090210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1778922/000210804426000004/form4-02092026_090210.xml","form_type":"4"}}]}